3,4-dihydroxyphenylacetic acid has been researched along with Cognitive Dysfunction in 3 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Cognitive Dysfunction: Diminished or impaired mental and/or intellectual function.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cognitive dysfunction is a severe issue of Alzheimer's disease." | 5.91 | Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage. ( Dou, X; Sun, L; Yang, W, 2023) |
| "Cognitive dysfunction is a severe issue of Alzheimer's disease." | 1.91 | Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage. ( Dou, X; Sun, L; Yang, W, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, L | 1 |
| Dou, X | 1 |
| Yang, W | 1 |
| Zubov, AS | 1 |
| Ivleva, IS | 1 |
| Pestereva, NS | 1 |
| Tiutiunnik, TV | 1 |
| Traktirov, DS | 1 |
| Karpenko, MN | 1 |
| Melief, EJ | 1 |
| Gibbs, JT | 1 |
| Li, X | 1 |
| Morgan, RG | 1 |
| Keene, CD | 1 |
| Montine, TJ | 1 |
| Palmiter, RD | 1 |
| Darvas, M | 1 |
3 other studies available for 3,4-dihydroxyphenylacetic acid and Cognitive Dysfunction
| Article | Year |
|---|---|
Propofol protects rats against intra-cerebroventricular streptozotocin-induced cognitive dysfunction and neuronal damage.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholinesterase; Animals; Cognitive Dysfunction; Dopamine; Hipp | 2023 |
Glibenclamide alters serotonin and dopamine levels in the rat striatum and hippocampus, reducing cognitive impairment.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cognitive Dysfunction; Corpus Striatum; Dopamine; Glyburide | 2022 |
Characterization of cognitive impairments and neurotransmitter changes in a novel transgenic mouse lacking Slc10a4.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Brain; Chromatography, High Pressure Liquid; | 2016 |